Quantcast

Latest bladder cancer Stories

2014-07-21 23:09:32

The Actos Lawsuit Filed on Behalf of a NY Man Who Developed Baldder Cancer Alleges Takedea Pharmaceuticals America Inc., Knew Their Diabetic Medication Caused Bladder Cancer But Did Not Inform Doctors and Patients Columbus, OH (PRWEB) July 21, 2014 The defective drug attorneys at Wright & Schulte LLC have filed an Actos lawsuit on behalf of a Schenectady, New York man who alleges that he developed bladder cancer as a result of taking Actos for more than a year to treat his Type II...

2014-07-18 08:24:51

BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided a key regulatory update on its flagship Phase 3 program, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory high grade non-muscle invasive bladder cancer. MCNA U.S. Regulatory Update Following several months of active dialogue with the U.S. Food and Drug Administration (FDA),...

2014-07-06 23:01:27

The Firm is evaluating Actos lawsuits on behalf of long-term users of the Type 2 diabetes medication who allegedly developed bladder cancer due to Actos. (PRWEB) July 06, 2014 The federal court overseeing thousands of Actos lawsuits (http://www.theactoslawsuitcenter.com/) that allege long-term use of the Type-2 diabetes drug caused patients to develop bladder cancer held a Status Conference on June 19, 2014, Bernstein Liebhard LLP reports. According court documents filed in the U.S....

2014-07-01 16:30:36

Micromedic to continue developing its CellDetect® technology for monitoring the recurrence of bladder cancer TEL AVIV, Israel, July 1, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (OTC: BLGTY)(TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that Micromedic Technologies (TASE: MCTC), BioLight's cancer diagnostic cluster company, achieved successful...

2014-06-24 14:07:18

Centro Nacional de Investigaciones Oncologicas (CNIO) New mutations in cohesin proteins, which are closely associated with cell division, are very common in various types of cancers such as bladder cancer and melanoma Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation. A good example of this is cohesin, a ring-shaped protein complex that embraces DNA to control cell division. Just a few months ago, and...

2014-06-20 23:07:43

In light of Blue Cross and Blue Shield of Massachusetts’ recent Actos lawsuit, Flood Law Group announces it is investigating potential Actos claims. Washington, DC (PRWEB) June 20, 2014 Flood Law Group announces it is now available to investigate potential Actos claims after a recent lawsuit announcement by Blue Cross and Blue Shield of Massachusetts. The lawsuit was filed June 11, 2014. According to documents in case No. 6:14-cv-01159, Blue Cross and Blue Shield of Massachusetts is...

2014-06-17 08:29:08

SAN DIEGO, June 17, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced that mocetinostat, the company's spectrum selective HDAC inhibitor, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration as a treatment for myelodysplastic syndrome (MDS). Mocetinostat is being developed in Phase 2 clinical studies in combination with Vidaza as a treatment for intermediate and high-risk MDS, as well as a single agent treatment in patients with...

2014-06-03 12:15:53

Yale University A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types, researchers report. Yale Cancer Center played a key role in the study, the results of which will be presented Saturday, May 31 at the 2014 annual conference of the American Society of Clinical Oncology (ASCO) in Chicago. The trial included 68 people with previously...

2014-06-01 23:01:25

The Firm is investigating Actos lawsuits on behalf of Type 2 diabetes patients who allegedly developed bladder cancer due to their use of the medication. New York, New York (PRWEB) June 01, 2014 Thousands of Actos lawsuits (http://www.theactoslawsuitcenter.com/) that allege the use of the Type 2 diabetes medication can increase the risk that a patient will develop bladder cancer continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of...

2014-05-28 08:32:22

DUNEDIN, New Zealand and HERSHEY, Pa., May 28, 2014 /PRNewswire/ -- Pacific Edge announced today that it has entered into a contractual agreement with MultiPlan, Inc. for diagnostic laboratory testing. The agreement includes Pacific Edge's participation in the MultiPlan, PHCS and PHCS Savility Networks. http://photos.prnewswire.com/prnvar/20131015/MM98246LOGO The agreement is the fourth signed with national provider networks by Pacific Edge since October 2013 and is another step in...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'